5 reports of this reaction
1.7% of all DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE reports
#14 most reported adverse reaction
LOSS OF CONSCIOUSNESS is the #14 most commonly reported adverse reaction for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, manufactured by RB Health (US) LLC. There are 5 FDA adverse event reports linking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE to LOSS OF CONSCIOUSNESS. This represents approximately 1.7% of all 298 adverse event reports for this drug.
DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE has an overall safety score of 75 out of 100. Patients taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE who experience loss of consciousness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LOSS OF CONSCIOUSNESS is a less commonly reported adverse event for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to loss of consciousness, the following adverse reactions have been reported for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE:
The following drugs have also been linked to loss of consciousness in FDA adverse event reports:
LOSS OF CONSCIOUSNESS has been reported as an adverse event in 5 FDA reports for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
LOSS OF CONSCIOUSNESS accounts for approximately 1.7% of all adverse event reports for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, making it a notable side effect.
If you experience loss of consciousness while taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.